2 ms·
Maybe you're right, but I think it's more likely that Pfizer, as a business, is more willing to accept risk in the pursuit of its core business aims than in its
by clucas 4y ago
Maybe you're right, but I think it's more likely that Pfizer, as a business, is more willing to accept risk in the pursuit of its core business aims than in its accounting, and that's all we're seeing. https://slatestarcodex.com/2019/01/14/too-many-people-dare-call-it-conspiracy/ https://slatestarcodex.com/2019/01/14/too-many-people-dare-c...
- s1artibartfast 4y agoIt could also be that the endeavor of drug discovery and manufacture is inherently more risky than accounting. From the academic sense, it is not a field of mathematical certainty, but one of subjective risk-benefit tradeoffs.